The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Percutaneous access and closure using the MANTA vascular closure device in transaxillary transcatheter aortic valve implantation

EuroIntervention 2020;16:266-268. DOI: 10.4244/EIJ-D-19-00809

1. Cardiovascular Theme, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden; 2. Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 3. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden


Introduction

The transaxillary (TAx) arterial access is used for transcatheter aortic valve implantation (TAVI) when the transfemoral (TF) access is inappropriate.

The TAx access is traditionally obtained through surgical cut-down, with the patient under general anaesthesia. More recently, a percutaneous TAx procedure has been developed1. At our centre, a modified percutaneous TAx approach has been used as an alternative access since 2017 using the novel MANTA® (Essential Medical [now Teleflex], Malvern, PA, USA) vascular closure device (VCD) to achieve haemostasis2. The MANTA is approved for vascular closure after TF TAVI but so far there is limited experience ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Left atrial appendage closure versus medical therapy for atrial fibrillation: the APPLY study